Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

25.58+0.1000+0.39%Vol 2.17K1Y Perf 37.87%
Sep 23rd, 2021 10:56 DELAYED
BID25.50 ASK25.62
Open25.42 Previous Close25.48
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     59.15
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★★     73.67
Price Range Ratio 52W %
88.41 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.00 Standard Deviation0.09
Beta1.12 

Today's Price Range

25.4225.60

52W Range

17.1126.69

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-0.43%
1 Month
0.39%
3 Months
-0.86%
6 Months
7.97%
1 Year
37.87%
3 Years
35.89%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FBIOP25.580.10000.39
AAPL146.710.86000.59
GOOG2 837.2218.45000.65
MSFT299.781.20000.40
XOM57.091.88003.41
WFC48.081.00002.12
JNJ165.601.67001.02
FB345.722.51000.73
GE104.055.51005.59
JPM161.385.47003.51
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.17K
Shares Outstanding0
Shares Float3.43M
Trades Count19
Dollar Volume164.67K
Avg. Volume13.37K
Avg. Weekly Volume2.39K
Avg. Monthly Volume4.77K
Avg. Quarterly Volume7.52K

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: FBIOP) stock closed at 25.48 per share at the end of the most recent trading day (a 0.12% change compared to the prior day closing price) with a volume of 2.38K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 93 people. Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock CEO is Lindsay A. Rosenwald.

The one-year performance of Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock is 37.87%, while year-to-date (YTD) performance is 31.41%. FBIOP stock has a five-year performance of %. Its 52-week range is between 17.11 and 26.69, which gives FBIOP stock a 52-week price range ratio of 88.41%

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 1.66, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -9.46%, a ROC of -13.54% and a ROE of -38.58%. The company’s profit margin is -%, its EBITDA margin is -162.80%, and its revenue ttm is $52.65 Million , which makes it $15.36 revenue per share.

Of the last four earnings reports from Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock has a dividend yield of 9.17% with a dividend per share of $2.34 and a payout ratio of -%.

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock has a Sell technical analysis rating based on Technical Indicators (ADX : 15.91, ATR14 : 0.28, CCI20 : -59.71, Chaikin Money Flow : 0.08, MACD : -0.05, Money Flow Index : 45.00, ROC : -1.58, RSI : 46.50, STOCH (14,3) : 34.38, STOCH RSI : 0.29, UO : 45.76, Williams %R : -65.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

CEO: Lindsay A. Rosenwald

Telephone: +1 781 652-4500

Address: 2 Gansevoort Street, New York 10014, NY, US

Number of employees: 93

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

20%80%

Bearish Bullish

57%43%

Bearish Bullish

62%38%

News

Stocktwits